Sage Journals: Discover world-class research

Abstract

Activation of ret/IPTC-1 has been documented in a minority of papillary thyroid carcinomas (PTC). In a recent study, the authors' group detected the presence of ret/IPTC-1 in association with a background of florid lymphocytic thyroiditis (LT) in 58% of cases of PTC studied, which prompted them to examine the incidence of RET/PTC-1 expression in 27 examples of various forms of nonlymphomatous lymphoid infiltration of the thyroid by using TaqMan RT-PCR. Overall, 21 cases (78%) were found to express the chimeric transcript of ret/IPTC-1. Eighteen cases of Hashimoto thyroiditis were positive (95%), and, of these, three had concomitant PTC while the remainder had no histologic evidence of associated malignancy. Three cases of lymphocytic thyroiditis demonstrated activated ret/PTC-1 (43%), two having associated PTC. These data suggest either that ret/PTC-1 is an indicator of follicular thyroid cell activation or that ret/PTC-1 activation is an early event in malignant transformation. If the latter is the case, it may be that, in a defined subset of the cell population, ret/IPTC-1 activation elicits an autoimmune response, which, while possibly curtailing the development of PTC in the majority of cases, results in destruction of the thyroid parenchyma.

Keywords

Hashimoto thyroiditis ret/IPTC-1 TaqMan RT-PCR

Get full access to this article

View all access options for this article.

References

1. McGee JO'D , Isaacson P , Wright NA (eds), The thyroid gland, vol. 2b, ch. 26 in Oxford textbook of pathology. Oxford University Press, pp. 1951-1954, 1992

2. Grieco M , Santoro M , Berlingieri MT , et al. PTC is a novel rearranged form of the ret protooncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557-563, 1990

3. Rabes HM , Demidchik EP , Siderow JD , et al. Pattern of radiation-induced RET and NTRK rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: Biological, phenotypic, and clinical implications. Clin Cancer Res 6:1093-1103, 2000

4. Grieco M , Cerrato A , Santoro M , Fusco A , Melillo RM , Vecchio G. Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. Oncogene 9:2531-2535, 1994

5. Sheils O , O'Leary J , Sweeney E. Involvement of ret/PTC-1 rearrangements in papillary carcinoma of the thyroid. J Pathol (in press).

6. Wirtschafter A , Schmidt R , Rosen D , et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope 1:95-100, 1997

7. Sheils O , Sweeney E. TSH receptor status of thyroid neoplasms-TaqMan RT-PCR analysis of archival material. J Pathol 188:87-92, 1999

8. Jhiang SM , Mazzaferri EL . The ret/PTC oncogene in papillary thyroid carcinoma. J Lab Clin Med 123:331-337, 1994

9. Santoro M , Carlomagno F , Hay ID , et al. RET oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 89:1517-1522, 1992

10.

10. Soares P , Fonesca E , Wynford-Thomas D , Sobrinhosimés M. Sporadic retrearranged papillary carcinoma of the thyroid: A subset of slow growing, less aggressive thyroid neoplasms. J Pathol 185:71-78, 1998

11.

11. Sugg SL , Zheng L , Rosen IB , Freeman JL , Ezzat S , Asa SL . ret/IPTC-1, -2, and -3 oncogene rearrangement in human thyroid carcinomas: Implications for metastatic potential. J Clin Endocrinol Metab 81:3360-3365, 1996

12.

12. Bouancer A , Wicker R , Caillou B et al. High prevalence of activating ret protooncogene rearrangements, in thyroid tumours from patients who had received external radiation. Oncogene 15:1263-1273, 1997

13.

13. Lam AKY , Montone KT , Nolan KA , Livolsi VA . Ret activation in papillary thyroid carcinoma: Prevalence and implication on the histological parameters. Human Pathol 29:565-568, 1998

14.

14. Yap AS , Stevenson BR , Cooper V , Manley S. Protein tyrosine phosphorylation influences adhesive junction assembly and follicular organization of cultured thyroid epithelial cells. Endocrinology 138:2315-2324, 1997

15.

15. Fischer AH , Bond JA , Taysavang P , Battles OE , Wynford-Thomas D. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Am J Pathol 153:1443-1450, 1998

ret/PTC-1 Activation in Hashimoto Thyroiditis

Abstract

Keywords

Get full access to this article

References